Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Famke L SchneidersHans J J van der Vliet

Abstract

CD1d-restricted invariant natural killer T (iNKT) cells constitute an important immunoregulatory T cell subset that can be activated by the synthetic glycolipid α-galactosylceramide (α-GalCer) and initiate antitumor immune responses. As cancer patients are frequently treated with aminobisphosphonates (NBP), it is relevant to determine possible effects of NBP on CD1d-restricted glycolipid Ag-presentation to iNKT cells. We report a striking reduction of α-GalCer-induced iNKT cell activation by monocyte derived dendritic cells (moDC) upon their exposure to NBP during maturation. We found that production of apolipoprotein E (apoE), which is a known facilitator of trans-membrane transport of exogenously derived glycolipids, was significantly diminished in moDC exposed to NBP. As the inhibitory effect of NBP on iNKT cell activation was alleviated by exogenous apoE, our data indicate that reduced apoE production by antigen presenting cells (APC) through NBP limits glycolipid-induced iNKT cell activation. This should be taken into account in the design of iNKT cell-based anti-cancer therapies.

References

Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·H KosekiM Taniguchi
Jul 7, 1997·The Journal of Experimental Medicine·M ExleyS Porcelli
Mar 27, 2003·Nature Reviews. Immunology·S Brian Wilson, Terry L Delovitch
May 5, 2004·The Journal of Experimental Medicine·Leonid S MetelitsaRobert C Seeger
Jun 23, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Hans J J van der VlietRik J Scheper
Oct 7, 2005·Nature·Peter van den ElzenMichael B Brenner
Oct 26, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tsuyoshi TachibanaMasayuki Imamura
Nov 19, 2011·The Journal of Steroid Biochemistry and Molecular Biology·Mustafa H IssaRosario D C Hirata
Nov 30, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Famke L SchneidersHans J van der Vliet
Jan 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Famke L SchneidersHans J van der Vliet
Oct 16, 2012·The Journal of Clinical Investigation·Stefan FreigangLuc Teyton

❮ Previous
Next ❯

Citations

Feb 15, 2020·Cancers·Zuzanna LukasikKoen Venken

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Famke L SchneidersHans J J van der Vliet
Cancer Immunology Research
Famke L SchneidersHans J J van der Vliet
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Weihua SongNikhil C Munshi
Clinical Immunology : the Official Journal of the Clinical Immunology Society
Andrew E HoganDonal O'Shea
Current Opinion in Immunology
Rosanna M McEwen-SmithVincenzo Cerundolo
© 2021 Meta ULC. All rights reserved